A specific protein disorder catalyzer of HIV-1 Nef

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The HIV-1 auxiliary protein Nef is required for the onset and progression of AIDS in HIV-1-infected persons. Here, we have deciphered the mode of action of a second-generation inhibitor of Nef, DLC27-14, presenting a competitive IC 50 of ∼16 μM measured by MALDI-TOF experiments. Thermal protein denaturation experiments revealed a negative effect on stability of Nef in the presence of a saturating concentration of the inhibitor. The destabilizing action of DLC27-14 was confirmed by a HIV protease-based experiment, in which the protease sensitivity of DLC27-14-bound Nef was three times as high as that of apo Nef. The only compatible docking modes of action for DLC27-14 suggest that DLC27-14 promotes an opening of two α-helices that would destabilize the Nef core domain. DLC27-14 thus acts as a specific protein disorder catalyzer that destabilizes the folded conformation of the protein. Our results open novel avenues toward the development of next-generation Nef inhibitors. © 2011 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Lugari, A., Breuer, S., Coursindel, T., Opi, S., Restouin, A., Shi, X., … Morelli, X. (2011). A specific protein disorder catalyzer of HIV-1 Nef. Bioorganic and Medicinal Chemistry, 19(24), 7401–7406. https://doi.org/10.1016/j.bmc.2011.10.051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free